Pro MedicusPMDIY +3.45%77 3-Year ROIIC % is 121.31 as of Jun. 2025, which is 8% below its 10-year median of 132.04. GuruFocus rates PMDIY with a GF Score™ of 77/100 and a GF Value™ of $39.65 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 619 Healthcare Providers & Services companies, Pro Medicus ranks better than 89.82% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Pro Medicus's 3-Year ROIIC % for the quarter that ended in Jun. 2025 was 121.31%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Pro Medicus's 3-Year ROIIC % or its related term are showing as below:
PMDIY's 3-Year ROIIC % is ranked better than 89.82% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.28
vs PMDIY: 121.31
Pro Medicus (OTCPK:PMDIY) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Pro Medicus 3-Year ROIIC % Related Terms
Pro Medicus 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Pro Medicus's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMDIY vs VEEV, BTSG, TEM: 3-Year ROIIC % Comparison
For the Health Information Services subindustry, Pro Medicus's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro Medicus 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Pro Medicus's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Pro Medicus (PMDIY) has a 3-Year ROIIC % of 121.31 as of Jun. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Pro Medicus and its competitors. This is near median its historical median of 132.04. Over the past decade, Pro Medicus' 3-Year ROIIC % has ranged from 41.89 to 204.67. According to the industry distribution chart, Pro Medicus ranks #63 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 10.2%.
Is Pro Medicus' 3-Year ROIIC % too high?
Pro Medicus' current 3-Year ROIIC % of 121.31 is near median its 10-year median of 132.04. Over the past 10 years, this metric has ranged from a low of 41.89 to a high of 204.67. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.28. Pro Medicus' value of 121.31 is 3598.5% above this industry median. Based on the distribution chart, Pro Medicus ranks #63 out of 619 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pro Medicus has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' 3-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Pro Medicus ranks #63 out of 619 companies for 3-Year ROIIC %. This places Pro Medicus in the top 10% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.28. Pro Medicus' value of 121.31 is 3598.5% above this benchmark. Historically, Pro Medicus' own 3-Year ROIIC % has ranged from 41.89 to 204.67 over the past decade. While the company's 10-year median is 132.04 vs. the industry median of 3.28, Pro Medicus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.28, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro Medicus's current 3-Year ROIIC % of 121.31 is 3598.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Pro Medicus and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro Medicus's current 3-Year ROIIC % is 121.31, which is near median its own 10-year median of 132.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (PMDIY) is currently considered Modestly Undervalued. The stock's GF Value™ is $39.65, compared to a current price of $30.00 — trading 24.3% below its estimated fair value. The current 3-Year ROIIC % is 121.31, which is near median its 10-year median of 132.04 and 3598.5% above the Healthcare Providers & Services industry median of 3.28. Pro Medicus' overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Pro Medicus (PMDIY), the current 3-Year ROIIC % is 121.31 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro Medicus (PMDIY) Overvalued in 2026?
Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued.
The current stock price of $30.00 is trading 24.3% below its estimated GF Value™ of $39.65.
GuruFocus considers Pro Medicus to be Modestly Undervalued.
Key valuation signals for PMDIY:
3-Year ROIIC %: 121.31 (near median its 10-year median of 132.04)
GF Value™: $39.65 vs. price of $30.00 (24.3% below fair value)
Industry Position: 3598.5% above the Healthcare Providers & Services median (#63 of 619)
No single metric tells the full story. See the PMDIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
77GF Score
Get the complete analysis for PMDIY
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMDIY has been successfully added to your 
